Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Alexander Bukreyev

Laboratory of Infectious Diseases

National Institute of Allergy and Infectious Diseases

National Institutes of Health

Bethesda

USA

[email]@nih.gov

Name/email consistency: medium

[Claim this account]

Affiliations

Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA. 2001 - 2008
Building 50, Room 6505, NIAID, NIH, 50 South Dr., USA. 2006

References

Newcastle disease virus as a vaccine vector for humans. Bukreyev, A., Collins, P.L. Curr. Opin. Mol. Ther. (2008) [Pubmed]
Successful topical respiratory tract immunization of primates against Ebola virus. Bukreyev, A., Rollin, P.E., Tate, M.K., Yang, L., Zaki, S.R., Shieh, W.J., Murphy, B.R., Collins, P.L., Sanchez, A. J. Virol. (2007) [Pubmed]
Nonsegmented negative-strand viruses as vaccine vectors. Bukreyev, A., Skiadopoulos, M.H., Murphy, B.R., Collins, P.L. J. Virol. (2006) [Pubmed]
Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus. Bukreyev, A., Belyakov, I.M., Prince, G.A., Yim, K.C., Harris, K.K., Berzofsky, J.A., Collins, P.L. J. Virol. (2005) [Pubmed]
Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. Bukreyev, A., Lamirande, E.W., Buchholz, U.J., Vogel, L.N., Elkins, W.R., St Claire, M., Murphy, B.R., Subbarao, K., Collins, P.L. Lancet (2004) [Pubmed]
More antibody with less antigen: can immunogenicity of attenuated live virus vaccines be improved?. Bukreyev, A., Skiadopoulos, M.H., McAuliffe, J., Murphy, B.R., Collins, P.L., Schmidt, A.C. Proc. Natl. Acad. Sci. U.S.A. (2002) [Pubmed]
Expression of immunomodulating molecules by recombinant viruses: can the immunogenicity of live virus vaccines be improved?. Bukreyev, A., Belyakov, I.M. Expert. Rev. Vaccines (2002) [Pubmed]
Granulocyte-macrophage colony-stimulating factor expressed by recombinant respiratory syncytial virus attenuates viral replication and increases the level of pulmonary antigen-presenting cells. Bukreyev, A., Belyakov, I.M., Berzofsky, J.A., Murphy, B.R., Collins, P.L. J. Virol. (2001) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.